MENU
STOK
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Stoke Therapeutics (STOK) Ownership - Who owns Stoke Therapeutics?
Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine... Show more
Profile
Industry
N/A
Address
45 Wiggins Avenue
Phone
+1 781 430-8200
Employees
110
Web
https://www.stoketherapeutics.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.01B
P/E Ratio
21.28
Total Cash
247.71M
Projected Growth
N/A
Total Debt
2.3M
Revenue
199.89M
Risk (Beta)
1.41
Dividend Yield
N/A
Total Cash/Share
4.52
Total Debt/Equity
N/A
Revenue/Share
3.43 USD as % of share price
Fundamentals
STOK
Capitalization
1.01B
P/E Ratio
21.28
Risk (Beta)
1.41
Dividend Yield
N/A
Total Cash
248M
Total Cash/Share
4.52
Total Debt
2.3M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
3.43%
Revenue
200M
ROE
N/A
Book Value
335M
P/B Ratio
3.03
Cash Flow
N/A
Earnings
0.91
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
5K
Current Ratio
6.98
Current Revenue Per Employee
107945.31
Dividends Per Share - Security
N/A
EBITDA
42.3M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
15.16
Shares Held By Institutions
661M
Shares Outstanding - Current
54.8M
Total Liabilities
49.6M
Total Volume MTD
N/A
Value
N/A
Gain YTD
67.815
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. STOK showed earnings on August 12, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
a company, which engages in the research and development of treatments for genetic diseases.
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
45 Wiggins Avenue
Phone
+1 781 430-8200
Employees
110
Web
https://www.stoketherapeutics.com